Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) has earned an average recommendation of “Moderate Buy” from the ten research firms that are covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation, seven have issued a buy recommendation and one has assigned a strong buy recommendation to the […]
Related Keywords
Canada , Leerink Partnrs , Relay Therapeutics Inc , Hsbc Holdings , Life Insurance Co , Nasdaq , Russell Investments Group Ltd , Great West Life Assurance Co , Relay Therapeutics Company Profile , Royal Bank , Relay Therapeutics , Get Free Report , Investments Group , West Life Assurance , Get Free , Relay Therapeutics Daily , Nasdaq Rlay , Arlay , Medical , Ratings , Consensus ,
comparemela.com © 2020. All Rights Reserved.